Multivariant Covid vaccine booster shows promise, early data suggests
3 years ago

Multivariant Covid vaccine booster shows promise, early data suggests

Deccan Chronicle  

London: A COVID-19 vaccine booster aimed at tackling multiple coronavirus variants shows promise in inducing a comprehensive immune response, early data suggests. The initial phase one clinical data shows the vaccine has strong levels of neutralising antibodies, similar to approved mRNA vaccines, but at up to a 10-fold lower dose in the first 10 individuals. "These initial data with samRNA Covid programme strongly support its unique approach of CD8+ T cell priming and potent neutralising antibody generation with a dose of samRNA potentially up to 10-fold lower than that required for first generation mRNA vaccines," said Professor Andrew Ustianowski from the University of Manchester. According to Allen, the vaccine will generate an immune state that may offer more robust clinical protection against current and future SARS-CoV-2 variants and be a first step towards developing a pan-coronavirus vaccine.

Cell Spike Vaccine Gritstone Early Data  booster  vaccines  vaccine  sarscov2  early  data  immunity  suggests  cell  variants  generation  covid  immune  multivariant  samrna  spike  promise  shows

History of this topic

Why Americans are opting out of getting a COVID booster shot
1 month, 2 weeks ago

Why Americans are opting out of getting a COVID booster shot

Daily Mail  

A recent survey reveals that a significant number of Americans are unlikely to get a COVID-19 booster vaccine this season. Conducted by the Pew Research Center between October 21 and 27, the survey of 9,593 U.S. adults found that 60% of respondents said they would 'probably not' get an updated vaccine. A full 81% of Republicans said they probably wouldn't …

PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccin
1 month, 3 weeks ago

PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccin

Live Mint  

MUMBAI, India & HYDERABAD, India – Business Wire India PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using machine learning-enabled computational protein design, is pleased to announce that it has been selected for inclusion in the U.S. Government’s Project NextGen. As part of this initiative, the National Institute of Allergy and Infectious Diseases, part of the …

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine
4 months, 1 week ago

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine

Hindustan Times  

In a recent development, Hyderabad-based Indian Immunologicals Ltd in collaboration with Griffith University in Australia has made a significant breakthrough in COVID-19 vaccination technology. Indian Immunologicals Ltd unveils first needle-free booster vaccine “This accomplishment signifies a major step forward in our battle against COVID-19. According to the press release, the innovative vaccine sports an attenuated formulation that uses advanced codon …

Indian Immunologicals Ltd develops needle-free COVID-19 intranasal booster vaccine in collaboration with Australian university
4 months, 1 week ago

Indian Immunologicals Ltd develops needle-free COVID-19 intranasal booster vaccine in collaboration with Australian university

The Hindu  

Hyderabad-headquartered vaccine manufacturer Indian Immunologicals Ltd, in partnership with Griffith University, Australia has developed a needle-free intra-nasal booster vaccine against SARS-CoV-2, a press release from the company stated. According to the press release, codon de-optimisation involves decreasing the frequency of underrepresented codon pairs without changing the amino acid sequences. K. Anand Kumar, managing director, Indian Immunologicals Limited said as per …

Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
6 months, 4 weeks ago

Past COVID infections may help protect against certain colds. Could it lead to better vaccines?

Associated Press  

If you’ve been sick with COVID-19, you may have some protection against certain versions of the common cold. A new study suggests previous COVID-19 infections lower the risk of getting colds caused by milder coronavirus cousins, which could provide a key to broader COVID-19 vaccines. “We think there’s going to be a future outbreak of a coronavirus,” said Dr. Manish …

What study on Covishield versus Covaxin vaccine reveals
10 months ago

What study on Covishield versus Covaxin vaccine reveals

The Hindu  

March 07, 2024 10:59 am | Updated March 09, 2024 10:53 am IST - Bengaluru A new study by a consortium of 11 institutes, led by scientists from the National Centre for Biological Sciences, has found that the Covishield vaccine demonstrated more robust immune responses compared to Covaxin. The key findings state that Covishield, leveraging a virus vector to deliver …

Does frequently updating COVID-19 vaccines have any benefits? | Explained
10 months, 3 weeks ago

Does frequently updating COVID-19 vaccines have any benefits? | Explained

The Hindu  

Researchers update the composition of influenza vaccines every six months to match the strains of the virus that are circulating in the wild, so that the shots may provide protective immunity against the flu. The VE of COVID-19 vaccines varies according to the disease’s progression as well as the circulating strains. Thus, researchers worldwide rushed to revise COVID-19 vaccines that …

IISc comes up with warm vaccine against current strains of SARS-CoV-2
1 year ago

IISc comes up with warm vaccine against current strains of SARS-CoV-2

The Hindu  

A heat-tolerant vaccine developed by the Indian Institute of Science researchers is said to be effective against all current strains of SARS-CoV-2 besides having the potential to be quickly adapted for future variants as well. According to IISc-Bengaluru, since the beginning of the COVID-19 pandemic, Prof. Raghavan Varadarajan from the institute’s Molecular Biophysics Unit and collaborators have been working on …

What To Know About New COVID Boosters And Who Is Eligible
1 year, 3 months ago

What To Know About New COVID Boosters And Who Is Eligible

Huff Post  

aire images via Getty Images “The vaccines are our single best method to protect ourselves from COVID, to protect our friends, family, loved ones, classmates, co-workers, etcetera, from COVID,” said Dr. S. Wesley Long. the way to think about these new COVID vaccines is it’s really like the annual flu shot,” Long said. “The recommendation from CDC’s advisory committee will …

Scientists inch closer to Covid vaccine that provides lifelong protection
1 year, 8 months ago

Scientists inch closer to Covid vaccine that provides lifelong protection

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Scientists have shown that a new Covid vaccine provides more durable …

COVID fourth dose might not work if…, expert on how to tackle new variant surge
1 year, 8 months ago

COVID fourth dose might not work if…, expert on how to tackle new variant surge

Live Mint  

The COVID-19 pandemic has brought about many challenges, one of which is the emergence of new variants of the virus that can evade immunity conferred by existing vaccines. While booster doses can still reduce the severity of the disease, experts are of the opinion that it may be time for governments to start thinking about second-generation vaccines. And, one of …

The COVID virus has mutated so much since 2019 that some experts say it should be renamed SARS-CoV-3
1 year, 8 months ago

The COVID virus has mutated so much since 2019 that some experts say it should be renamed SARS-CoV-3

Salon  

On Monday, April 10, President Joe Biden signed a bill that immediately terminated the COVID-19 national emergency, first enacted in 2020 as the SARS-CoV-2 virus gripped the country. "This virus remains unstable — it has not settled into a predictable pattern, which means surveillance systems need to be sensitive to pick up the early signs of another surge." Related Pandemic …

Centre rolls out first nasal Covid vaccine as booster
1 year, 11 months ago

Centre rolls out first nasal Covid vaccine as booster

Hindustan Times  

India on Thursday rolled out the first nasal vaccine against Covid-19, to be administered as a primary or booster dose for adults, potentially widening the pool of people who may take a third vaccine against the infection, cutting tertiary costs, and easing pressures on supply and storage networks. “Being the world’s first intranasal Covid-19 vaccine, this marks a glorious tribute …

FDA’s advisors back plan to simplify COVID-19 vaccinations
1 year, 11 months ago

FDA’s advisors back plan to simplify COVID-19 vaccinations

LA Times  

Syringes with COVDI-19 vaccines are prepared at a free public clinic in Lynwood last year. “We’re still protected against severe disease, thank goodness,” even after the latest Omicron strains cropped up, said FDA advisor Dr. Paul Offit, a vaccine expert at Children’s Hospital of Philadelphia. The first step: The FDA advisory panel voted unanimously that people should get the same …

No need for fourth dose of COVID-19 vaccine given current evidence, says Dr Raman Gangakhedkar
1 year, 11 months ago

No need for fourth dose of COVID-19 vaccine given current evidence, says Dr Raman Gangakhedkar

Firstpost  

Pune: Dr Raman Gangakhedkar, former head of epidemiology and communicable diseases at the Indian Council of Medical Research, on Tuesday, discounted the need to take the fourth dose of COVID-19 vaccine given the current evidence regarding the coronavirus and variants. “Looking at the current evidence, it is not that big that there is any need for the fourth dose of …

Covishield Immune Responses Against Covid Variants Higher Than Covaxin: Study
2 years ago

Covishield Immune Responses Against Covid Variants Higher Than Covaxin: Study

News 18  

Neutralising antibody responses against the SARS-COV-2 virus and its variants of concern are higher among Covishield recipients than those who took the indigenously made Covaxin, according to a multi-centre study. Covishield elicited immune responses of higher magnitude and breadth than Covaxin in both seronegative individuals and seropositive individuals, across cohorts representing the pre-vaccination immune history of the majority of the …

As COVID-19 spikes in California, booster shots could make all the difference
2 years, 1 month ago

As COVID-19 spikes in California, booster shots could make all the difference

LA Times  

With coronavirus cases and hospitalizations rising in Los Angeles County, officials are voicing new confidence in the effectiveness of the updated COVID-19 booster shot. New data has found that the updated COVID-19 vaccines offer “significant additional protection” against symptomatic infection in people who were previously vaccinated or boosted with the older formula. “We have seen very low uptake of the …

COVID-19 vaccines offer significant protection against reinfection: Study
2 years, 1 month ago

COVID-19 vaccines offer significant protection against reinfection: Study

India TV News  

COVID-19 vaccine: A recent study revealed that people earlier infected with the SARS-CoV-2 virus still benefit from vaccination against COVID-19, gaining 60% to 94% protection against reinfection. “In our study, we find a significant vaccine effectiveness against SARS-CoV-2 reinfection, and this shows the importance of vaccination also for those who might be protected by natural immunity," said Katrine Finderup Nielsen …

RNA vaccines rose to prominence during COVID, but we've only scratched the surface of their potential
2 years, 1 month ago

RNA vaccines rose to prominence during COVID, but we've only scratched the surface of their potential

ABC  

In high school biology, students are taught the central concept of genetics in a very simple way: DNA makes RNA, RNA makes protein, and protein makes life. There's more inside the RNA universe Vaccines that contain messenger RNA, or mRNA, have been studied for decades, but the release of them during the COVID-19 pandemic was the first of its kind. …

Covid booster shot campaign opens to everyone 12 and up
2 years, 2 months ago

Covid booster shot campaign opens to everyone 12 and up

NL Times  

Everyone aged 12 and older can now make an appointment for a repeat vaccination against the coronavirus, the RIVM and GGD reported. That means that everyone who qualifies for the booster shot can get one at a vaccination location. People aged 12 and older can get the repeat vaccination if it has been at least three months since their previous …

CORBEVAX offers better immunity as a heterologous booster shot
2 years, 2 months ago

CORBEVAX offers better immunity as a heterologous booster shot

Deccan Chronicle  

HYDERABAD: Heterologous booster shots have gained significance in light of the waning effect of vaccine doses, especially against different variants of the Covid-19 virus. There is an increase in the immune response to the administration of heterologous booster shots on two counts – first cellular immunity and second, neutralizing antibodies. Administering the CORBEVAX vaccine as a heterologous booster dose provides …

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences
2 years, 3 months ago

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences

News 18  

India will soon roll out mRNA shots and intranasal vaccines, which will be available on CoWIN, and can be used as boosters against Covid-19. India’s first mRNA shot is only the third mRNA vaccine to be approved for Covid-19 in the world after Pfizer and Moderna. But mortality will be reduced.” Sharing a study of the intranasal vaccines under clinical …

Experimental COVID-19 vaccine could outsmart future coronavirus variants
2 years, 3 months ago

Experimental COVID-19 vaccine could outsmart future coronavirus variants

LA Times  

A nurse prepares a syringe of COVID-19 vaccine. “We think of it as a one-time solution for all the COVID variants,” said Haitao Hu, an immunologist at the University of Texas Medical Branch and senior author of a study describing the vaccine in Wednesday’s edition of the journal Science Translational Medicine. The situation has forced scientists to play catch-up with …

‘Big boost’: Bharat Biotech’s nasal Covid-19 vaccine gets green light
2 years, 4 months ago

‘Big boost’: Bharat Biotech’s nasal Covid-19 vaccine gets green light

Hindustan Times  

Bharat Biotech's Covid-19 nasal vaccine was cleared for use in adults on Tuesday. The BBV154 intranasal vaccine received emergency use authorisation from the Drugs Controller General of India after it was proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials. BBV154 is believed to produce local antibodies in the upper respiratory tract which may provide the …

U.S. authorizes updated COVID-19 boosters targeting newest variants
2 years, 4 months ago

U.S. authorizes updated COVID-19 boosters targeting newest variants

LA Times  

The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common Omicron strains. “Give a clear, forward-looking set of expectations.” Here’s the rub: The original vaccines still offer strong protection against severe disease and death from COVID-19 for most generally healthy people, especially if they got that important first booster dose. First, FDA …

Tweaked COVID boosters close but how much will they help?
2 years, 4 months ago

Tweaked COVID boosters close but how much will they help?

Associated Press  

COVID-19 vaccines tweaked to better match today’s omicron threat are expected to roll out in a few weeks but still up in the air is how much benefit the booster shots will offer, who should get one -- and how soon. Dr. Peter Marks, the FDA’s vaccine chief, said Thursday that once authorized, the tweaked boosters could help right away …

Tweaked COVID boosters are close, but how much will they help?
2 years, 4 months ago

Tweaked COVID boosters are close, but how much will they help?

LA Times  

Pre-loaded syringes are ready for use at a school in New Orleans. Dr. Peter Marks, the FDA’s vaccine chief, said Thursday that once authorized, the tweaked boosters could help right away — while BA.5 infections still are too high — and hopefully blunt yet another winter surge. To evaluate the combo shots, the FDA is using data from human testing …

The hunt for a universal Covid-19 vaccine
2 years, 4 months ago

The hunt for a universal Covid-19 vaccine

BBC  

The hunt for a universal Covid-19 vaccine Getty Images The first Covid-19 vaccines that work on all variants might be available as early as 2024. Getty Images Many coronaviruses that can infect humans, such as Mers, are in the beta genus Variant-proof vaccines All scientists agree that a truly universal vaccine, which could protect against every single coronavirus that might …

US health officials urge booster shots as COVID variants spread
2 years, 5 months ago

US health officials urge booster shots as COVID variants spread

Al Jazeera  

The administration of US President Joe Biden pushes vaccines as the best way to avoid potential disruptions from new BA.4 and BA.5 variants. “Staying up to date on your COVID-19 vaccines provides the best protection against severe outcomes.” Walensky said the US has seen a doubling in the number of hospitalisations due to COVID-19 since April, reflecting the spread of …

Will Americans have the right COVID-19 vaccine this fall? Maybe
2 years, 5 months ago

Will Americans have the right COVID-19 vaccine this fall? Maybe

LA Times  

A man walks underneath the marquee of the Alex Theatre in Glendale. Determining which recipe should go into those doses to induce optimal protection — the vaccine’s “composition” — is an exercise in educated guesswork. Getting a timely and accurate fix on all this “is truly a challenge, and it is science at its hardest,” Dr. Peter Marks, the U.S. …

Multipronged vaccine protects against COVID virus family members — even some still in hiding
2 years, 6 months ago

Multipronged vaccine protects against COVID virus family members — even some still in hiding

LA Times  

Researchers at Caltech have devised an experimental vaccine that targets an array of coronaviruses and variants in a single shot. “We’ve had three pandemics or epidemics in the past 20 years: first SARS, then MERS, then SARS-CoV-2,” said Caltech biochemist Pamela Bjorkman, who led the new work. More outbreaks sparked by “spillover events” are inevitable, she said, and “we want …

FDA advisers recommend updating COVID booster shots for fall
2 years, 6 months ago

FDA advisers recommend updating COVID booster shots for fall

Associated Press  

At least some U.S. adults may get updated COVID-19 shots this fall, as government advisers voted Tuesday that it’s time to tweak booster doses to better match the most recent virus variants. Their combination shots, what scientists call “bivalent” vaccines, substantially boosted levels of antibodies capable of fighting that variant, more than simply giving another dose of today’s vaccine. Marks …

FDA advisors recommend updating COVID booster shot formula for fall
2 years, 6 months ago

FDA advisors recommend updating COVID booster shot formula for fall

LA Times  

Advisors to the Food and Drug Administration are recommending that some U.S. adults get a modified COVID-19 booster shot this fall that better matches the recent variants. Some U.S. adults are a step closer to getting updated COVID-19 boosters this fall, as government advisors voted Tuesday that it’s time to tweak the shots to better match the most recent virus …

FDA grapples with whether to modify COVID vaccine for fall
2 years, 6 months ago

FDA grapples with whether to modify COVID vaccine for fall

LA Times  

The Food and Drug Administration will debate Tuesday whether it’s time to update COVID vaccine formulas. “This is science at its toughest,” said FDA vaccine chief Dr. Peter Marks, adding that a final decision is expected within days of the advisory panel’s recommendation. In an analysis prepared for Tuesday’s meeting, FDA officials acknowledged targeting last winter’s version of Omicron is …

CEPI Ties Up With Bharat Biotech, Others to Make a 'Variant-Proof' COVID Vaccine
2 years, 7 months ago

CEPI Ties Up With Bharat Biotech, Others to Make a 'Variant-Proof' COVID Vaccine

The Quint  

"BBIL has successfully commercialised a universal COVID-19 vaccine for adults and children. The University of Sydney will provide a framework for pre-clinical assessment of vaccine candidates, together with access to Australia's world-class early phase clinical trial community," said Professor James Triccas, Sydney Institute for Infectious Diseases, The University of Sydney. "Our technological platform for innovative protein designs was used in …

New oral Covid vaccine can decrease severity, transmission: Study
2 years, 8 months ago

New oral Covid vaccine can decrease severity, transmission: Study

India Today  

An investigational Covid vaccine designed to be administered orally has not only limited the degree of the disease but also decreased its airborne spread during its trial on animals, revealed a study published in the journal, Science Translational Medicine, earlier this week. The research team led by Duke University researcher Stephanie N Langel, a medical instructor in the Department of …

Covid nasal spray could be next leap in coronavirus vaccine development
2 years, 8 months ago

Covid nasal spray could be next leap in coronavirus vaccine development

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. open image in gallery Omicron persisted despite vaccinations "I don’t feel the research establishment should …

US regulators approve 2nd COVID booster for those aged 50 and up
2 years, 9 months ago

US regulators approve 2nd COVID booster for those aged 50 and up

Al Jazeera  

US has seen a small uptick in new COVID-19 cases during the past week, raising concern that infections could surge again. Regulators in the United States have authorised another COVID-19 booster shot for people aged 50 and older, amid concerns that coronavirus infections may begin rising again due to waning immunity to Omicron variants. “Based on an analysis of emerging …

Second COVID booster shot does little to stop Omicron, study finds
2 years, 9 months ago

Second COVID booster shot does little to stop Omicron, study finds

LA Times  

Dr. Jacov Lavee receives a fourth dose of the Comirnaty vaccine in Ramat Gan, Israel, as part of a trial to test whether a second COVID-19 booster shot helps protect against infection and illness. Compared to getting two initial doses and one booster shot of Pfizer and BioNTech’s Comirnaty vaccine, adding a second booster shot reduced the rate of coronavirus …

WHO says COVID-19 boosters needed, reversing previous call
2 years, 10 months ago

WHO says COVID-19 boosters needed, reversing previous call

LA Times  

An expert group convened by the World Health Organization said Tuesday that it “strongly supports urgent and broad access” to booster doses of COVID-19 vaccines amid the global spread of Omicron, capping a reversal of the U.N. agency’s repeated insistence last year that boosters weren’t necessary for healthy people and contributed to vaccine inequity. In a statement, WHO said its …

Op-Ed: Will the next coronavirus variant escape our best immune defenses?
2 years, 10 months ago

Op-Ed: Will the next coronavirus variant escape our best immune defenses?

LA Times  

An image of the coronavirus, shown as orange, emerging from the surface of cells, in green, cultured in a lab. Studies show that the strength of our long-lived T-cell response to the virus’ proteins — especially by T cells that recognize the spike protein — strongly correlates with the degree of protection. Rather, T-cell recognition occurs when a viral protein …

COVID-19 pandemic: Novavax says protein vaccine works for kids as young as 12
2 years, 10 months ago

COVID-19 pandemic: Novavax says protein vaccine works for kids as young as 12

India TV News  

Highlights On Feb 10, Novavax announced that its COVID vaccine proved safe, effective in study of 12-17 yr olds Novavax makes a protein-based vaccine- a different type than the most widely used shots Novavax plans to soon seek expanded use of its shots down to age 12 Novavax announced on Thursday that its COVID-19 vaccine proved safe and effective in …

COVID-19 vaccine booster provides effective antibody protection against Omicron, says Lancet study
2 years, 11 months ago

COVID-19 vaccine booster provides effective antibody protection against Omicron, says Lancet study

Firstpost  

COVID-19 Vaccine Booster | The study found that in people who had received the Pfizer vaccine for all three doses, antibody levels against Omicron after a third dose were similar to those previously reached against Delta after only two shots. London: A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of …

Explained: Why T cell vaccines could be the key to long-term immunity from COVID-19
2 years, 11 months ago

Explained: Why T cell vaccines could be the key to long-term immunity from COVID-19

Firstpost  

Many of the doses designed to date – including Moderna’s, Pfizer’s and AstraZeneca’s – have focused just on the spike protein of the coronavirus. The main types are B cells, which make antibodies, and T cells, which either support B cell antibody production or act as killer cells to destroy the virus. This knowledge suggests that, against COVID, a good …

Common cold T cells may offer protection against Covid-19: UK study
2 years, 11 months ago

Common cold T cells may offer protection against Covid-19: UK study

India Today  

People with higher levels of T cells from common cold coronaviruses are less likely to become infected with SARS-CoV-2, the strain which causes Covid-19, according to a new UK study led by Indian-origin researchers on Monday. Our study provides the clearest evidence to date that T cells induced by common cold coronaviruses play a protective role against SARS-CoV-2 infection. These …

T-cells from common colds can provide protection against COVID-19 - study
2 years, 11 months ago

T-cells from common colds can provide protection against COVID-19 - study

Live Mint  

High levels of T-cells from common cold coronaviruses can provide protection against COVID-19, an Imperial College London study published on Monday has found, which could inform approaches for second-generation vaccines. Immunity against COVID-19 is a complex picture, and while there is evidence of waning antibody levels six months after vaccination, T-cells are also believed to play a vital role in …

Early data of COVID-19 vaccine booster to tackle multiple variants shows promise
3 years ago

Early data of COVID-19 vaccine booster to tackle multiple variants shows promise

Firstpost  

The yet-to-be peer-reviewed results also show the vaccine, being trialled with the anticipated involvement of 20 people aged 60 and over, was generally safe and well-tolerated. London: A COVID-19 vaccine booster aimed at tackling multiple coronavirus variants shows promise in inducing a comprehensive immune response, early data suggests. The initial phase one clinical data shows the vaccine has strong levels …

Multivariant Covid vaccine booster shows promise, early data suggests
3 years ago

Multivariant Covid vaccine booster shows promise, early data suggests

India Today  

A Covid-19 vaccine booster aimed at tackling multiple coronavirus variants shows promise in inducing a comprehensive immune response, early data suggests. The initial phase one clinical data shows the vaccine has strong levels of neutralising antibodies, similar to approved mRNA vaccines, but at up to a 10-fold lower dose in the first 10 individuals. "These initial data with samRNA Covid …

EXPLAINED: It's Not Only The Novel Coronavirus That Can Keep Changing, Vaccines Could Too
3 years ago

EXPLAINED: It's Not Only The Novel Coronavirus That Can Keep Changing, Vaccines Could Too

News 18  

It’s been little over a year since the first vaccines against Covid-19 were rolled out under emergency approvals. But given the suggestion that “it’s just a little naive to think that the vaccines that we made in the first few hot minutes of the pandemic are the best vaccines that we can make”, there’s focus now on coming up with …

Discover Related